Deltex Medical Group plc
DTXMF · OTC
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $992 | $1,064 | $359 | $1,059 |
| % Growth | -6.8% | 196.8% | -66.1% | – |
| Cost of Goods Sold | $305 | $353 | $323 | $351 |
| Gross Profit | $687 | $711 | $36 | $708 |
| % Margin | 69.3% | 66.8% | 9.9% | 66.9% |
| R&D Expenses | $208 | $84 | $98 | $96 |
| G&A Expenses | $495 | $597 | $220 | $321 |
| SG&A Expenses | $749 | $859 | $697 | $1,158 |
| Sales & Mktg Exp. | $254 | $262 | $129 | $214 |
| Other Operating Expenses | $874 | $210 | $0 | $0 |
| Operating Expenses | $1,831 | $1,153 | $795 | $1,254 |
| Operating Income | -$1,144 | -$442 | -$401 | -$546 |
| % Margin | -115.3% | -41.5% | -111.9% | -51.6% |
| Other Income/Exp. Net | -$107 | -$104 | -$56 | $278 |
| Pre-Tax Income | -$1,251 | -$546 | -$789 | -$576 |
| Tax Expense | $0 | $0 | -$44 | -$39 |
| Net Income | -$1,251 | -$546 | -$719 | -$538 |
| % Margin | -126.1% | -51.3% | -200.6% | -50.8% |
| EPS | -0.001 | -0 | -0 | -0.001 |
| % Growth | -133.3% | 25% | 50% | – |
| EPS Diluted | -0.001 | -0 | -0 | -0.001 |
| Weighted Avg Shares Out | 1,898,331 | 1,895,833 | 1,662,946 | 704,724 |
| Weighted Avg Shares Out Dil | 1,895,531 | 1,891,934 | 1,659,202 | 703,228 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $104 | $111 | $119 |
| Depreciation & Amortization | -$16 | $39 | $75 | $58 |
| EBITDA | -$404 | -$403 | -$123 | -$151 |
| % Margin | -40.7% | -37.9% | -34.3% | -14.2% |